Cancer/testis antigens: An expanding family of targets for cancer immunotherapy

Immunological Reviews

Volumn 188, Issue , 2002, Pages 22-32

  Scanlan, Matthew J ^a   Gure, Ali O ^a   Jungbluth, Achim A ^a   Old, Lloyd J ^a   Chen, Yao Tseng ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; CANCER VACCINE; MAGE A ANTIGEN; MAGE A3 PEPTIDE VACCINE; NY ESO1 ANTIGEN; SSX ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACETYLATION; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER FAMILY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; EPITOPE MAPPING; FEMALE; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE TARGETING; GERM CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; MAGE A GENE; MALE; METHYLATION; MOLECULAR CLONING; MULTIGENE FAMILY; NY ESO 1 GENE; OVARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; SERODIAGNOSIS; SOMATIC CELL GENETICS; SSX GENE; TROPHOBLAST; X CHROMOSOME; ACTIVE IMMUNIZATION; ANTIBODY SPECIFICITY; CLASSIFICATION; GENE EXPRESSION; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM; REVIEW; TESTIS;

ANTIGENS, NEOPLASM; CANCER VACCINES; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOTHERAPY; IMMUNOTHERAPY, ACTIVE; MALE; NEOPLASMS; ORGAN SPECIFICITY; OVARY; TESTIS; TROPHOBLASTS;

EID: 0036813331     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18803.x     Document Type: Article

References (94)

1. van der Bruggen P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;154:1643-1647.
2. Traversari C, et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992;35:145-152.
3. De Plaen E, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-369.
4. Boel P, et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-175.
5. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-698.
6. De Backer O, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999;59:3157-3165.
7. Wang MG, Zakut R, Yi H, Rosenberg S, McBride OW. Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28. Cytogenet Cell Genet 1994;67:116-119.
8. Sahin U, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995;92:11810-11813.
9. Türeci Ö, et al. Expression of SSX genes in human tumors. Int J Cancer 1998;77:19-23.
10. Gure AO, et al. SSX. A multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997;72:965-971.
11. Chen YT, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94:1914-1918.
12. Lethe B, et al. LAGE-1, a new gene with tumor specificity. Int J Cancer 1998;76:903-908.
13. Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenet Cell Genet 1997;79:237-240.
14. Chen YT et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 1998;95:6919-6923.
15. Türeci Ö, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998;95:5211-5216.
16. Sahin U, et al. Expression of cancer testis genes in human brain tumors. Clin Cancer Res 2000;6:3916-3922.
17. Eichmüller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 2001;98:629-634.
18. Ono T, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci 2001;98:3282-3287.
19. Cho B, et al. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 2002;292:715-726.
20. Güre AO, et al. CT10. A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 2000;85:726-732.
21. Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res 2000;60:3848-3855.
22. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res 1999;59:6223-6229.
23. Westbrook VA, et al. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol Reprod 2000;63:469-481.
24. De Wit N, Weidle UH, Ruitter DJ, van Muijen GNP. Expression profiling of MMA-1 and splice variant MMA-1B: New cancer/testis antigens identified in human melanoma. Int J Cancer 2002;98:547-553.
25. Scanlan MJ, et al. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett 2000;150:155-164.
26. Scanlan MJ, et al. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002;98:485-492.
27. Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, Pastan I. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc Natl Acad Sci USA 1998;95:10757-10762.
28. Brinkmann U, Vasmatzis G, Lee B, Pastan I. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database. Cancer Res 1999;59:1445-1448.
29. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 2000;60:4752-4755.
30. Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN. The XAGE family of cancer/testis-associated genes: Alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 2002;99:361-369.
31. Feller AJ, Duan Z, Penson R, Toh HC, Seiden MV. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma. Anticancer Res 2000;20:4147-4151.
32. Debinski W, Gibo DM. Molecular expression analysis of restrictive receptor for interleukin 13, a brain minor-associated cancer/testis antigen. Mol Med 2000;6:440-449.
33. Crew AJ, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995;14:2333-2340.
34. Jungbluth AA, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-860.
35. Sahin U, et al. Expression of multiple cancer/testis antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies. Int J Cancer 1998;78:387-389.
36. Mashino K, et al. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer 2001;85:713-720.
37. Li J, et al. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res 1996;2:1619-1625.
38. Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol 1997;9:684-693.
39. Naka N, et al. Expression of SSX genes in human osteosarcomas. Int J Cancer 2002;98:640-642.
40. Stockert E, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998;187:1349-1354.
41. Chen YT, et al. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 1994;91:1004-1008.
42. Jungbluth AA, et al. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer 2001;94:252-256.
43. Kocher T, et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res 1995;55:2236-2239.
44. Dos Santos NR, et al. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 2000;60:1654-1662.
45. Jungbluth AA, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000;85:460-465.
46. Jungbluth AA, et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 2000;83:493-497.
47. Chen YT, Stockert E, Jungbluth A et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996;93:5915-5919.
48. Brasseur F, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995;63:375-380.
49. Goydos JS, Patel M, Shih W. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. J Surg Res 2001;98:76-80.
50. Patard JJ, et al. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 1995;64:60-64.
51. Kurashige T, et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade. Cancer Res 2001;61:4671-4674.
52. van Baren N, et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 1999;94:1156-1164.
53. Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma. Frequency of expression and correlation with prognostic parameters. Mod Pathol 2000;13:459-465.
54. Gure A, Wei I, Old LJ, Chen YT. The SSX gene family: Characterization of nine complete genes. Int J Cancer 2002; in press.
55. Chand A, Clark J, Cooper CS, Craig IW. Long-range organization of reiterated sequences, including the SSX1 cDNA at the OATL1 cluster in Xp11.23. Genomics 1995;30:545-552.
56. Aradhya S, et al. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet 2001;10:2557-2567.
57. Weber J, et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 1994;54:1766-1771.
58. Shichijo S, et al. Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2′-deoxycytidine. Jpn J Cancer Res 1996;87:751-756.
59. Weiser TS, et al. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J Immunother 2001;24:151-161.
60. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089-1093.
61. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93:7149-7153.
62. De Smet C, et al. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 1995;42:282-290.
63. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line-and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999;19:7327-7335.
64. Old LJ. Cancer/testis (CT) antigens - A new link between gametogenesis and cancer. Cancer Immunity 2001;1:1 [epub].
65. Meuwissen RL, Offenberg HH, Dietrich AJ, Riesewijk A, van Iersel M, Heyting C. A coiled-coil related protein specific for synapsed regions of meiotic prophase chromosomes. EMBO J 1992;11:5091-5100.
66. Baba T, et al. An acrosomal protein, sp32, in mammalian sperm is a binding protein specific for two proacrosins and an acrosin intermediate. J Biol Chem 1994;269:10133-10140.
67. Vidaeus CM, von Kapp-Herr C, Golden WL, Eddy RL, Shows TB, Herr JC. Human fertilin beta: Identification, characterization, and chromosomal mapping of an ADAM gene family member. Mol Reprod Dev 1997;46:363-369.
68. Primakoff P, Myles DG. The ADAM gene family. Surface proteins with adhesion and protease activity. Trends Genet 2000;16:83-87.
69. Bellefroid EJ, Poncelet DA, Lecocq PJ, Revelant O, Martial JA. The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc Natl Acad Sci USA 1991;88:3608-3612.
70. Tamkun JW, et al. Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SW12. Cell 1992;68:561-572.
71. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993;365:855-859.
72. Roldan ER. Role of phospholipases during sperm acrosomal exocytosis. Front Biosci 1998;3:D1109-D1119.
73. Jiang Y, Tsai TF, Bressler J, Beaudet AL. Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev 1998;8:334-342.
74. Gerard M, Hernandez L, Wevrick R, Stewart CL. Disruption of the mouse necdin gene results in early post-natal lethality. Nat Genet 1999;23:199-202.
75. Muscatelli F, et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000;9:3101-3110.
76. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999;274:16242-16248.
77. Matsumoto K, Taniura H, Uetsuki T, Yoshikawa K. Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters. Gene 2001;272:173-179.
78. Salehi AH, et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000;17:279-288.
79. Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 2002;277:22541-22546.
80. Jordan BW, et al. Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem 2001;276:39985-39989.
81. Renkvist N, Castelli C, Robbins PF, Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 2001;50:3-15.
82. Scanlan MJ, et al. Humoral immunity to human breast cancer. Antigen definition and quantitative analysis of mRNA expression. Cancer Immunity 1:4 [epub].
83. Jager E, et al. Humoral immune responses of cancer patients against 'Cancer-Testis' antigen NY-ESO-1: Correlation with clinical events. Int J Cancer 1999;84:506-510.
84. Jager E, et al. Monitoring CD8 T cell responses to NY-ESO-1. Correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 2000;97:4760-4765.
85. Jager E, et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998;187:265-270.
86. Gnjatic S, et al. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci USA 2000;97:10917-10922.
87. + T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000;191:625-630.
88. + T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. J Immunol 2000;165:1153-1159.
89. + T cells. Cancer Res 2000;60:4946-4952.
90. Marchand M, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999;80:219-230.
91. Coulie PG, et al. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA 2001;98:10290-10295.
92. Jäger E, et al. Induction of primary NY-ESO-1 immunity: CD8 T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1 + cancers. Proc Natl Acad Sci USA 2000;97:12198-12203.
93. Serrano A, et al. Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment. Int J Cancer 2001;94:243-251.
94. Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 1995;92:4987-4991.